Rigel Pharmaceuticals Inc...

NASDAQ: RIGL · Real-Time Price · USD
39.55
1.66 (4.38%)
At close: Aug 15, 2025, 3:59 PM
39.51
-0.10%
After-hours: Aug 15, 2025, 07:58 PM EDT

Rigel Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
59.61M 11.45M 14.34M 12.42M -1.03M -8.25M 737K -5.69M -6.6M -13.54M 1.4M -19.04M -13.49M -27.45M -22.64M -20.95M -13.82M 39.5M
Depreciation & Amortization
607K 604K 604K 611K 613K 400K 293K 292K 296K 357K 284K 240K 237K 237K 404K 261K 258K 239K
Stock-Based Compensation
3.28M 3.32M 2.09M 2.64M 2.53M 5.13M 1.93M 1.94M 2.17M 2.76M 4.08M 2.71M 2.39M 3.21M 2.34M 2.2M 2.31M 2.64M
Other Working Capital
18.17M -18.17M 7.39M 4.39M 5.08M -4.96M -3.5M 1.91M 2.26M -1.72M -5.83M 1.61M 1.93M -3.32M -795K 3.64M -56.42M 67.62M
Other Non-Cash Items
-49.04M -190K -332K 2.26M 10.33M 2.87M -370K -1.94M -2.17M 279K 148K -203K -174K 710K 825K 886K 1.37M 60K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -3.99M 1.82M 2.18M n/a n/a n/a n/a n/a 116K 76K 10K 85K
Change in Working Capital
16.08M -16.08M -2.2M 3.75M -1.65M -2.1M -8.83M 2.23M 10.06M 6.07M -27.82M 2.99M -1.87M -2.35M -129K 7.23M 65.09M -62.48M
Operating Cash Flow
30.54M -893K 14.5M 21.68M 302K -5.01M -6.24M -1.36M 5.93M -4.07M -21.91M -13.3M -12.91M -25.64M -19.09M -10.3M 55.22M -19.95M
Capital Expenditures
n/a n/a -26K 350K -222K -138K -110K -22K n/a -15M -73K -189K 36K -224K 21K -170K -407K -71K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 110K 22K n/a 127K n/a 279K 264K n/a -21K 170K 407K 71K
Purchase of Investments
-39.03M -21.65M -17.71M -2.21M -7.55M -7.8M -12.98M -9.44M -8.78M -127K -2.85M -19.05M -264K -7M -24.38M -45.63M -67.15M -4.3M
Sales Maturities Of Investments
15.75M 11.1M 6.75M 6M 18.7M 8.25M 6M 8.25M 11.75M 15.65M 21.17M 29.42M 20.8M 29.85M 30.85M 1.4M 17.9M 11.9M
Other Investing Acitivies
n/a n/a 72K -334K 10.93M 313K 110K 22K 2.97M 127K 350K 279K 264K 22.85M 21K -170K -407K -71K
Investing Cash Flow
-23.28M -10.55M -10.91M 3.8M 10.93M 313K -6.87M -1.17M 2.97M 777K 18.6M 10.46M 21.09M 22.63M 6.49M -44.4M -49.66M 7.53M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a 19.95M n/a 9.6M -33K 9.97M n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-484K 484K 1.47M -9.84M -752K -2.6M 486K -878K -373K -827K -2.1M -4.09M -6.23M -1.18M 1.08M 274K 59.22M 2.1M
Financial Cash Flow
418K 484K 1.47M -9.84M -752K -2.51M 486K -869K -373K 19.12M -2.1M 5.51M -5.66M 8.8M 1.08M 274K 59.22M 2.1M
Net Cash Flow
7.68M -10.96M 5.05M 15.64M 10.48M -7.21M -12.63M -3.4M 8.53M 15.83M -5.41M 2.67M 2.52M 5.79M -11.51M -54.42M 64.78M -10.33M
Free Cash Flow
30.54M -893K 14.48M 22.03M 80K -5.15M -6.35M -1.38M 5.93M -19.07M -21.98M -13.49M -12.88M -25.86M -19.07M -10.47M 54.81M -20.03M